FDA “Critical Path” Leads To Arizona; Rx Development Institute Being Formed

The Institute for Global Pharmaceutical Development expects to be operational in early 2005 with University of Arizona VP-Health Sciences Raymond Woosley, MD/PhD, as its head

More from Archive

More from Pink Sheet